Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.
This study has been completed.
Study NCT00212368   Information provided by Nobelpharma

First Received on September 13, 2005.   Last Updated on September 9, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Wison's Disease
Additional conditions recognized in this trial
Hepatolenticular Degeneration
More general conditions related to this trial
Basal Ganglia Diseases
Brain Diseases
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Central Nervous System Diseases
Digestive System Diseases
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Liver Diseases
Metabolic Diseases
Metabolism, Inborn Errors
Metal Metabolism, Inborn Errors
Movement Disorders
Nervous System Diseases
Neurodegenerative Diseases
Interventions listed in this trial
Zinc acetate
Additional drug interventions recognized in this trial
Zinc
More general drug interventions related to this trial
Growth Substances
Micronutrients
Pharmacologic Actions
Physiological Effects of Drugs
Trace Elements
Sponsors listed in this trial
Nobelpharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services